Investors are increasingly turning their attention to the cannabis sector as an intriguing alternative to the high-flying tech stocks, particularly those tied to artificial intelligence like Nvidia, which are trading at lofty valuations. Recent regulatory changes, including the U.S. rescheduling of FDA-approved marijuana products from Schedule I to Schedule III, signal potential growth for the cannabis industry, which could see its market value soar from approximately $138 billion this year to over $1.4 trillion by 2034, according to Fortune Business Insights.

While investing in cannabis stocks entails risks—such as Tilray Brands (TLRY) facing ongoing losses and cash burn—the potential for significant returns exists, especially with the prospect of further legalization and reform. Multi-state operators like Curaleaf Holdings and Trulieve Cannabis are also positioned to benefit from these regulatory shifts.

For growth-oriented investors, the current environment presents a compelling opportunity to consider cannabis stocks, particularly as valuations remain low and the market outlook appears promising.

Source: fool.com